Noven Therapeutics, LLC is recalling 27,713 boxes of Daytrana (methylphenidate transdermal system), a prescription skin patch used to treat ADHD. The recall affects three different dosage strengths (10 mg, 20 mg, and 30 mg) because the patches failed mechanical testing for peel and shear. This defect means the patches may be difficult to use or may not adhere and deliver medication correctly. Consumers should contact their healthcare provider or pharmacist to discuss alternative treatments or to determine if their specific box is affected.
The delivery system is defective because it is 'out of specification' for how the patch peels and adheres to the skin. This could lead to a failure in delivering the intended dose of medication or difficulty in applying the patch properly.
Healthcare provider consultation and pharmacy return
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.